Hypothesis Mitochondrial NAD+ deficiency in intestinal niche stromal cells (e.g., subepithelial myofibroblasts) links mtDNA heteroplasmy to Wnt/β‑catenin gradient loss by impairing exosomal Wntless secretion, thereby reducing β‑catenin activity in adjacent stem cells.

Mechanistic Rationale

1. Somatic mtDNA mutations clonally expand in progenitor and niche‑support cells, decreasing OXPHOS capacity and shifting metabolism toward glycolysis [PMC5924524].
2. This metabolic shift lowers the NAD⁺/NADH ratio, limiting SIRT1‑mediated deacetylation of transcriptional regulators that control Wntless (Evi) expression and the ESCRT‑III machinery required for exosome biogenesis [PMC6398523].
3. Reduced NAD⁺ also diminishes autophagic flux and mitophagy, causing accumulation of damaged mitochondria that further increase local ROS, oxidizing cysteine residues on Wntless and impairing its sorting into exosomes [Nature 2023].
4. Consequently, stromal cells secrete fewer Wnt‑laden exosomes, flattening the Wnt gradient across the crypt base [PMC5924524]. ISCs experience diminished β‑catenin stabilization, leading to reduced proliferation and a bias toward secretory lineages, while differentiated progenitors suffer metabolic stress and apoptosis, driving niche erosion.

Novel Insight The hypothesis shifts the focus from stem‑cell‑intrinsic mtDNA damage to stromal‑cell metabolic signaling as the proximate cause of Wnt gradient collapse, explaining why direct mtDNA interventions in stem cells fail to rescue function [PMC5924524].

Testable Predictions

• In PolG mutator mice, stromal‑specific overexpression of NAD⁺ biosynthetic enzyme NAMPT will restore stromal NAD⁺ levels without altering mtDNA heteroplasmy.
• This rescue will increase exosomal Wntless cargo (measured by Wntless‑GFP in stromal‑derived exosomes) and elevate β‑catenin reporter activity in Lgr5⁺ ISCs.
• Crypt proliferation, Paneth cell number, and lineage balance will improve to wild‑type levels despite persistent mtDNA mutations.
• Conversely, stromal‑specific NAMPT knockdown in young mice will phenocopy aging: reduced exosomal Wnt, lowered Wnt/β‑catenin signaling, and accelerated niche erosion even with wild‑type mtDNA.

Falsifiability If stromal NAD⁺ boosting fails to increase exosomal Wntless or β‑catenin signaling in ISCs, or if crypt phenotypes remain unchanged, the hypothesis is refuted, indicating that mtDNA influences niche signaling through a NAD⁺‑independent mechanism.

Experimental Outline

1. Generate Vimentin‑CreERT2; Rosa26‑lox‑STOP‑lox‑NAMPT mice crossed with PolGmut/mut mutator line.
2. Induce Cre in adult mice, confirm stromal NAD⁺ elevation via mass spectrometry.
3. Isolate stromal exosomes, quantify Wntless by Western blot and Wnt activity using TOPflash reporter in organoid cultures.
4. Perform lineage tracing (Lgr5‑CreERT2; Rosa26‑tdTomato) and apoptosis assays (cleaved‑caspase‑3) in crypts.
5. Compare to controls: PolGmut alone, wild‑type + stromal NAMPT overexpression, and stromal NAMPT knockdown in young wild‑type.

Impact Validating this mechanism would redirect therapeutic strategies toward metabolic rejuvenation of the niche (e.g., NAD⁺ precursors, SIRT1 agonists) rather than futile attempts to correct mtDNA in stem cells, aligning with the observation that longevity interventions targeting mtDNA alone have not restored stem cell function [PMC5924524].